GI bleeding after percutaneous coronary intervention among patients on dual antiplatelet therapy remains risky in terms of ...
Additionally, patients with permanent metal implants often require prolonged antiplatelet therapy, which increases the risk of bleeding complications. In response to these limitations, metal-free PCI ...
Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that it has entered into a know-how license agreement with Mayo Clinic to collaborate on the ...
Premature discontinuation of antiplatelet therapy is the most important predictor of stent thrombosis; therefore, patients who are candidates for implantation of drug-eluting stents should be ...
Background: There are currently no specific guidelines regarding pre-hospital antiplatelet therapy in patients with out-of-hospital cardiac arrest (OHCA) suspected of acute coronary syndrome (ACS).
Introduction: Antiplatelet therapy with aspirin has been recommended for patients with stroke and myocardial infarction (MI). Clinicians face challenges when they come across aspirin hypersensitivity ...
CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as ...
Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...
Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...
Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...
The therapeutic drug used in the study by Mori (2020) is an antiplatelet drug that includes aspirin and ... artery spasm,’ as well as ‘aspirin’ and ‘antiplatelet therapy’. Certain additional-related ...
Six patients had been receiving antiplatelet medications to prevent blood clotting ... Rituximab, a type of antibody therapy, ...